KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Change in Accured Expenses (2020 - 2026)

Aurinia Pharmaceuticals filings provide 6 years of Change in Accured Expenses readings, the most recent being $13.1 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 24.88% to $13.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.7 million, a 134.92% decrease, with the full-year FY2025 number at -$4.7 million, down 134.92% from a year prior.
  • Change in Accured Expenses hit $13.1 million in Q4 2025 for Aurinia Pharmaceuticals, up from -$641000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $17.5 million in Q4 2024 to a low of -$23.4 million in Q1 2025.
  • Median Change in Accured Expenses over the past 5 years was $539000.0 (2022), compared with a mean of $1.3 million.
  • Biggest five-year swings in Change in Accured Expenses: crashed 675.61% in 2021 and later skyrocketed 5931.36% in 2022.
  • Aurinia Pharmaceuticals' Change in Accured Expenses stood at $2.9 million in 2021, then crashed by 78.95% to $616000.0 in 2022, then plummeted by 44.48% to $342000.0 in 2023, then soared by 5007.89% to $17.5 million in 2024, then decreased by 24.88% to $13.1 million in 2025.
  • The last three reported values for Change in Accured Expenses were $13.1 million (Q4 2025), -$641000.0 (Q3 2025), and $6.3 million (Q2 2025) per Business Quant data.